{
    "code": "02017873",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02017873",
    "time": "2018-06-08 03:57:35",
    "許可證字號": "衛署藥輸字第017873號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "109\/04\/04",
    "發證日期": "103\/12\/05",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00201787302",
    "中文品名": "善得定注射液０．１毫克／毫升",
    "英文品名": "SANDOSTATIN AMPOULES 0.1MG\/ML",
    "適應症": "對手術、放射線療法或ＤＯＰＡＭＩＮＥ作用劑療法控制無效的肢端肥大症患者，可控制其症狀，並減少生長激素及ＳＯＭＡＴＯＭＥＤＩＮＥ－Ｃ的血漿值，解除與胃腸胰臟內分泌腫瘤有關的症狀，預防胰臟手術後的併發症，治療胃食道靜脈曲張出血及預防再出血",
    "劑型": "270注射劑",
    "包裝": "1毫升安瓿瓶裝 100瓶以下盒裝",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "主成分略述": [
        "OCTREOTIDE"
    ],
    "限制項目": "02輸　入",
    "申請商名稱": "1422701100  台灣諾華股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "F430099000  NOVARTIS PHARMA STEIN AG",
        "製造廠廠址": "SCHAFFHAUSERSTRASSE CH-4332 STEIN SWITZERLAND",
        "製造廠公司地址": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "6828001300",
            "成分名稱": "OCTREOTIDE",
            "含量描述": "",
            "含量": "0.0001000000",
            "單位": "GM"
        }
    ],
    "仿單外盒": [
        {
            "title": "Sandostatin sc-TWI-060318-107-04-24.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02017873&Seq=019&Type=9"
        },
        {
            "title": "Sandostatin 0.1mg-105-01-14(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02017873&Seq=003&Type=8"
        }
    ]
}